Valentina Tuninetti

[JCM MDPI @JCM_MDPI]

#mdpijcm
📢Call for reading
✅ Citations 4
PD-1 and PD-L1 Expression in #Endometrial_Cancer: A #SystematicReview of the Literature
by Orazio De Tommasi et al. 🏬 @unict_it @unito
@MediPharma_MDPI

[Valentina Tuninetti @valedoc87]

L’evoluzione del trattamento del tumore endometriale https://t.co/fzK0qKFUwI

[Valentina Tuninetti @valedoc87]

🍀

[Tumori Journal @TumoriJ]

Prescribing pattern of #anticoagulants in patients with cancer associated #thrombosis👉 #Results of a survey among Multicentre Italian Trials in Ovarian cancer and gynaecologic malignancies and @AIOMtweet

🔗https://t.co/MpXdx7YqKK

@valedoc87 @UgoDeGiorgi @MassimoDiMaio75

[Massimo Di Maio @MassimoDiMaio75]

Proud of this publication, the first original article in the new @bmj_company Oncology journal.

@LauraMarandino @EleonoraGhisoni @marialuciareale @paslombardi @JamesAimar @valedoc87 @chiaramallow @fabioturco92 @R_DiLiello @fperrone62

Tweetorial (1/6)

https://t.co/e8dyg3og7O

[Francesco Perrone @fperrone62]

Give a look to the MITO END-3 results just published in @TheLancetOncol . Free download through this link for a few weeks. https://t.co/KVkB7w4G9j

[AIOM @AIOMtweet]

Carcinoma mammario triplo negativo: parte la campagna di sensibilizzazione e awareness di AIOM.
Seguiteci nei prossimi mesi sui nostri canali social e su AIOM Tv.
-
#carcinomammario #aiom #triplonegativo #tumorealseno

[Massimo Di Maio @MassimoDiMaio75]

Let's discuss about integrating #PROMs patient-reported outcomes in clinical practice for #cancer patients

⏰ 11.00-11.45
📍 7.3 Rennes auditorium

@clacardone
#ESMO22 #ESMOYOC